Company Profiles

driven by the PitchBook Platform

CVRx

Description

Developer of implantable technology designed to provide treatment of high blood pressure. The company has developed Barostim neo which is designed to trigger the body's own natural blood flow regulation system to treat high blood pressure and heart failure, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.

2001

Founded

PRIVATE

Status

51-200

Employees

Series G

Latest Deal Type

$113M

Latest Deal Amount

$379M

Total Amount Raised

Description

Developer of implantable technology designed to provide treatment of high blood pressure. The company has developed Barostim neo which is designed to trigger the body's own natural blood flow regulation system to treat high blood pressure and heart failure, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.

Website:

www.cvrx.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Other Devices and Supplies
Surgical Devices

Primary Office

9201 West Broadway Avenue Suite 650 Minneapolis, MN 55445United States +1 (763) 416-2840
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore CVRx's full profile, request a free trial.

CVRx Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

CVRx Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

CVRx Investors (16)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
ABS VenturesVenture CapitalMinority000 0000000 0000
Action Potential Venture CapitalVenture CapitalMinority000 0000000 0000
DaVitaPE-Backed CompanyMinority000 0000000 0000
Frazier Healthcare PartnersGrowth/ExpansionMinority000 0000000 0000
Gilde Healthcare PartnersVenture CapitalMinority000 0000000 0000
ABS Ventures Venture Capital
Action Potential Venture Capital Venture Capital
DaVita PE-Backed Company
Frazier Healthcare Partners Growth/Expansion
Gilde Healthcare Partners Venture Capital

CVRx Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Nadim YaredPresident, Chief Executive Officer & Board Member
John BrintnallChief Financial Officer & Vice President, Finance & Administration
Robert Kieval Ph.DChief Technology Officer, Founder, Board Member and Executive Vice President
Jared OasheimController
Phillipe Wanstok Ph.DChief Commercial Officer
Nadim Yared President, Chief Executive Officer & Board Member
John Brintnall Chief Financial Officer & Vice President, Finance & Administration
Robert Kieval Ph.D Chief Technology Officer, Founder, Board Member and Executive Vice President
Jared Oasheim Controller
Phillipe Wanstok Ph.D Chief Commercial Officer

CVRx Board Members (16)

NameRepresentingRoleSinceContact
Info
Ali Behbahani MDNew Enterprise AssociatesPartner000 0000
Brad Vale Ph.DJohnson & Johnson Innovation - JJDCHead000 0000
Christopher EhrlichSelfBoard Member000 0000
Geoffery PardoGilde Healthcare PartnersPartner000 0000
James ShapiroThomas Weisel Partners GroupBoard Member000 0000
Ali Behbahani MD Partner New Enterprise Associates
Brad Vale Ph.D Head Johnson & Johnson Innovation - JJDC
Christopher Ehrlich Board Member Self
Geoffery Pardo Partner Gilde Healthcare Partners
James Shapiro Board Member Thomas Weisel Partners Group
Request full access to PitchBook